Skip to main content

Israel Molina Romero

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Israel Molina Romero

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Llicenciat en Medicina per la UAB. Adjunt del Servei de Malalties Infeccioses Hospital Universitari Vall d'Hebron. Responsable de la Unitat de Medicina Tropical i Salut Internacional de l'Hospital Vall d'Hebron. Director del Programa de Salut Internacional de l'ICS. Experiència clínica i de recerca a Guinea Ecuatorial, Brasil i Angola.

Projects

Pendent

IP: Israel Molina Romero
Collaborators: Adrián Sánchez Montalvá, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR18/00022
Duration: 31/03/2019 - 25/05/2023

PILOT PROJECT FOR THE SCREENING OF CHAGAS DISEASE IN COMMUNITY PHARMACIES

IP: Ines Mercedes Oliveira Souto
Collaborators: Susana Otero Romero, Israel Molina Romero, Fernando M Salvador Velez, Jordi Gómez i Prat, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Aroa Silgado Gimenez
Funding agency: Fundació La Marató de TV3
Funding: 121150
Reference: 20182610
Duration: 10/05/2019 - 31/01/2023

PICAT (Plataforma Integral per al Control d’ Arbovirosis a CaTalunya)

IP: Israel Molina Romero
Collaborators: Laia Perez Lasarte
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 91175.67
Reference: SLT006/17/00205
Duration: 01/03/2018 - 31/12/2019

Point-of-Care electroquímico para la detección rápida y cuantitativa de malaria

IP: Eva Baldrich Rubio
Collaborators: Francesc Zarzuela Serrat, Israel Molina Romero, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Ines Mercedes Oliveira Souto
Funding agency: Instituto de Salud Carlos III
Funding: 80410
Reference: DTS17/00145
Duration: 01/01/2018 - 31/12/2020

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Marta Fernandez Lobera

Marta Fernandez Lobera

Research technician
Research Group of Physical Medicine and Rehabilitation
Read more
Francisca Gallego Valades

Francisca Gallego Valades

Administration and Management
Read more
Melisa Gómez Pérez

Melisa Gómez Pérez

Research technician
Spine Research Unit
Read more
Marc Pellicer Sarasa

Marc Pellicer Sarasa

Biomedical Research in Cancer Stem Cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.